definiens: shall mean with respect to a Therapeutic Antibody Product, the gross amount invoiced by Buyer and any Affiliate or sublicensee or market ing partner to third party customers for such Thera peutic Antibody Product, less : ( a ) Normal and customary trade and quantity discoun ts and non - affiliated brokers ’ or agents ’ commissions actually allowed and taken and not alre ady reflected in the amount invoiced ; ( b ) Amounts repaid or credited by reason of defects, rejections, returns, recalls, allowances, or government - imposed retroactive price reductions ; ( c ) Third party cash rebates and chargebacks relate d to sales of finished Therapeutic Antibody Products, to the extent allowed ; ( d ) Government - imposed retroactive price reductions that are actually allowed or granted ; ( e ) Tariffs, duties, excise, sales, value - added, an d other consumption taxes and customs duties to the extent included in the invoice price and paid b y or on behalf of Buyer ; ( f ) Cash discounts for timely payment ; ( g ) Delayed ship order credits ; ( h ) Discounts pursuant to indigent patient programs and patient discount programs of any nature ; ( i ) A fixed charge of [ * * * ] to cover warehousing and distribution expenses ; ( j ) Any otherwise specifically identifiable costs o r charges included in the gross invoiced sales price of such Therapeutic Antibody Product falling within categories equivalent to those listed above ; and 6 [ * * * ] Certain information in this document has been omitted and filed separately with the Securities a nd Exchange Commission . Confidential Treatment has bee n requested with respect to the omitted portions